The FDA has approved Elanco Animal Health’s Zenrelia, a new oral medication for treating itching in dogs. While it shows promise, concerns have been raised regarding its efficacy and potential side effects compared to the market leader, Apoquel. The approval comes with a warning about vaccination timing, potentially impacting adoption by veterinarians.